207 related articles for article (PubMed ID: 15113745)
1. Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys.
Schweda F; Klar J; Narumiya S; Nüsing RM; Kurtz A
Am J Physiol Renal Physiol; 2004 Sep; 287(3):F427-33. PubMed ID: 15113745
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E receptor subtypes involved in stimulation of gastroduodenal bicarbonate secretion in rats and mice.
Takeuchi K; Ukawa H; Furukawa O; Kawauchi S; Araki H; Sugimoto Y; Ishikawa A; Ushikubi F; Narumiya S
J Physiol Pharmacol; 1999 Jun; 50(2):155-67. PubMed ID: 10424714
[TBL] [Abstract][Full Text] [Related]
3. Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse.
Nataraj C; Thomas DW; Tilley SL; Nguyen MT; Mannon R; Koller BH; Coffman TM
J Clin Invest; 2001 Oct; 108(8):1229-35. PubMed ID: 11602631
[TBL] [Abstract][Full Text] [Related]
4. Biphasic actions of prostaglandin E(2) on the renal afferent arteriole : role of EP(3) and EP(4) receptors.
Tang L; Loutzenhiser K; Loutzenhiser R
Circ Res; 2000 Mar; 86(6):663-70. PubMed ID: 10747002
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of renal prostaglandin receptor mRNAs by dietary salt intake in the rat.
Jensen BL; Mann B; Skøtt O; Kurtz A
Kidney Int; 1999 Aug; 56(2):528-37. PubMed ID: 10432392
[TBL] [Abstract][Full Text] [Related]
6. Role of EP(2) and EP(3) PGE(2) receptors in control of murine renal hemodynamics.
Audoly LP; Ruan X; Wagner VA; Goulet JL; Tilley SL; Koller BH; Coffman TM; Arendshorst WJ
Am J Physiol Heart Circ Physiol; 2001 Jan; 280(1):H327-33. PubMed ID: 11123248
[TBL] [Abstract][Full Text] [Related]
7. Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice.
Minami T; Nakano H; Kobayashi T; Sugimoto Y; Ushikubi F; Ichikawa A; Narumiya S; Ito S
Br J Pharmacol; 2001 Jun; 133(3):438-44. PubMed ID: 11375261
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E prevents indomethacin-induced gastric and intestinal damage through different EP receptor subtypes.
Kunikata T; Araki H; Takeeda M; Kato S; Takeuchi K
J Physiol Paris; 2001; 95(1-6):157-63. PubMed ID: 11595431
[TBL] [Abstract][Full Text] [Related]
9. Impaired bone resorption to prostaglandin E2 in prostaglandin E receptor EP4-knockout mice.
Miyaura C; Inada M; Suzawa T; Sugimoto Y; Ushikubi F; Ichikawa A; Narumiya S; Suda T
J Biol Chem; 2000 Jun; 275(26):19819-23. PubMed ID: 10749873
[TBL] [Abstract][Full Text] [Related]
10. EP(1) and EP(4) receptors mediate prostaglandin E(2) actions in the microcirculation of rat kidney.
Purdy KE; Arendshorst WJ
Am J Physiol Renal Physiol; 2000 Oct; 279(4):F755-64. PubMed ID: 10997926
[TBL] [Abstract][Full Text] [Related]
11. Characterization of prostaglandin E(2) receptors and their role in 24,25-(OH)(2)D(3)-mediated effects on resting zone chondrocytes.
Del Toro F; Sylvia VL; Schubkegel SR; Campos R; Dean DD; Boyan BD; Schwartz Z
J Cell Physiol; 2000 Feb; 182(2):196-208. PubMed ID: 10623883
[TBL] [Abstract][Full Text] [Related]
12. Characterization of PGE(2) receptors (EP) and their role as mediators of 1alpha,25-(OH)(2)D(3) effects on growth zone chondrocytes.
Sylvia VL; Del Toro F; Hardin RR; Dean DD; Boyan BD; Schwartz Z
J Steroid Biochem Mol Biol; 2001 Sep; 78(3):261-74. PubMed ID: 11595507
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E(2) protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apc(Min/+) mice.
Hansen-Petrik MB; McEntee MF; Jull B; Shi H; Zemel MB; Whelan J
Cancer Res; 2002 Jan; 62(2):403-8. PubMed ID: 11809688
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
15. Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis.
Mutoh M; Watanabe K; Kitamura T; Shoji Y; Takahashi M; Kawamori T; Tani K; Kobayashi M; Maruyama T; Kobayashi K; Ohuchida S; Sugimoto Y; Narumiya S; Sugimura T; Wakabayashi K
Cancer Res; 2002 Jan; 62(1):28-32. PubMed ID: 11782353
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 receptors EP2 and EP4 are down-regulated in human mononuclear cells after injury.
Strong VE; Winter J; Yan Z; Smyth GP; Mestre JR; Maddali S; Schaefer PA; Yurt RW; Stapleton PP; Daly JM
Surgery; 2001 Aug; 130(2):249-55. PubMed ID: 11490357
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E receptors and the kidney.
Breyer MD; Breyer RM
Am J Physiol Renal Physiol; 2000 Jul; 279(1):F12-23. PubMed ID: 10894784
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of [(3)H]-prostaglandin E(2) binding to the cloned human EP(4) prostanoid receptor.
Davis TL; Sharif NA
Br J Pharmacol; 2000 Aug; 130(8):1919-26. PubMed ID: 10952683
[TBL] [Abstract][Full Text] [Related]
19. Distinction between relaxations induced via prostanoid EP(4) and IP(1) receptors in pig and rabbit blood vessels.
Jones RL; Chan K
Br J Pharmacol; 2001 Sep; 134(2):313-24. PubMed ID: 11564649
[TBL] [Abstract][Full Text] [Related]
20. Regulation of TNFalpha and interleukin-10 production by prostaglandins I(2) and E(2): studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists.
Shinomiya S; Naraba H; Ueno A; Utsunomiya I; Maruyama T; Ohuchida S; Ushikubi F; Yuki K; Narumiya S; Sugimoto Y; Ichikawa A; Oh-ishi S
Biochem Pharmacol; 2001 May; 61(9):1153-60. PubMed ID: 11301049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
